Archive: 9/02/2017

Emflaza approved for duchenne muscular dystrophy

(HealthDay) —Emflaza (deflazacort) has been approved by the U.S. Food and Drug Administration to treat Duchenne muscular dystrophy in people five years and older, the agency said Thursday in a news release.

page 1 from 9